The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer healthcare business, Opella. Opella had launched the actual use trial (AUT) to support its planned switch of Cialis from a prescription to an over-the-counter (OTC) medicine.

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile dysfunction ((ED)) drug, Cialis. Read more here.